var data={"title":"Terbinafine (topical): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Terbinafine (topical): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/8194?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=terbinafine-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Terbinafine (topical): Patient drug information&quot;</a> and <a href=\"topic.htm?path=terbinafine-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Terbinafine (topical): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566190\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>LamISIL Advanced [OTC];</li>\n      <li>LamISIL AT Jock Itch [OTC];</li>\n      <li>LamISIL AT Spray [OTC];</li>\n      <li>LamISIL AT [OTC];</li>\n      <li>LamISIL Spray [DSC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566191\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Lamisil</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566196\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antifungal Agent, Topical</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568028\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>OTC labeling:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea pedis:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply between the toes to affected area once or twice daily for at least 1 week; apply on the bottom or sides of feet twice daily for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply to affected area once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Solution: Apply to affected area once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea corporis, Tinea cruris:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Solution: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Canadian products [Rx only]:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea pedis, Tinea corporis, Tinea cruris:</b> Topical: Cream, Spray: Apply to affected area(s) once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Cutaneous candidiasis:</b> Topical: Cream: Apply to affected area once or twice daily for 1 to 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea versicolor:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply to affected area once or twice daily for 1 to 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Spray: Apply to affected area twice daily for 1 week</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568027\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=terbinafine-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Terbinafine (topical): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Tinea pedis:</b> Children &ge;12 years and Adolescents: Topical: [OTC labeling]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Apply between the toes to affected area twice daily for at least 1 week; apply on the bottom or sides of feet twice daily for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gel, Solution: Refer to adult dosing .</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Tinea corporis, Tinea cruris:</b> Children &ge;12 years and Adolescents: [OTC labeling]: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568029\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247718\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT: 1% (12 g, 24 g, 30 g, 36 g, 42 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT Jock Itch: 1% (12 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (12 g [DSC], 15 g, 24 g [DSC], 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL Advanced: 1% (12 g) [contains alcohol, usp]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT Spray: 1% (30 mL [DSC], 125 mL) [contains alcohol, usp, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL Spray: 1% (30 mL [DSC]) [contains alcohol, usp]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566194\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10076341\" class=\"block foccan drugH1Div\"><span class=\"drugH1\">Dosage Forms: Canada</span>\n    <p style=\"text-indent:0em;display:inline\">Information with regard to form, strength, and availability of products uniquely available in Canada but currently not available in the US. Refer also to Dosage forms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream, topical, as hydrochloride:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Lamisil: 1%</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Solution, topical, as hydrochloride [spray]:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Lamisil: 1%</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23348555\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Wash affected area with soap and water prior to use and dry completely; wash hands after use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution: Hold 4 to 6 inches from skin during use.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247719\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Dermatologic fungal infections:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">US products [OTC]: Treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Canadian products [prescription only]: Treatment of dermatologic fungal skin infections (including tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and tinea versicolor) in adults.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566186\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Terbinafine may be confused with terbutaline</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247711\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Burning sensation of skin, contact dermatitis, exfoliation of skin, pruritus, skin irritation, skin rash, stinging of the skin, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Local irritation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9601565\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">There are no contraindications listed within the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Canadian labeling:</i> Hypersensitivity to terbinafine or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247709\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse events:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Local irritation: If irritation/sensitivity develops, discontinue therapy and institute appropriate alternative therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For topical use only. Not intended for ophthalmologic, oral, or vaginal administration. Do not use on nails or scalp.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300113\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247713\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9924&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568004\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events were not observed in animal reproduction studies with systemic terbinafine. Systemic absorption is limited following topical application. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568007\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Following oral administration, terbinafine is excreted into breast milk (refer to the Terbinafine [Systemic] monograph for additional information). Systemic absorption is limited following topical application. Nursing mothers should not apply topical formulations to the breast.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247707\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Synthetic allylamine derivative that inhibits squalene epoxidase, a key enzyme in sterol biosynthesis in fungi. This results in a deficiency in ergosterol within the fungal cell membrane and results in fungal cell death.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247721\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Limited (&lt;5%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Distributed to sebum and skin predominantly</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 14 to 35 hours </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9572927\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (LamISIL AT External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.58</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (LamISIL AT Jock Itch External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Terbinafine HCl External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $11.99</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (LamISIL Advanced External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.72</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (LamISIL AT Spray External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (125 mL): $8.93</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961914\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Amizil (PH);</li>\n      <li>Antifan (CZ, EE);</li>\n      <li>Binter (LK);</li>\n      <li>Derfin (BD);</li>\n      <li>Dermasil (IL);</li>\n      <li>Dermifene (PH);</li>\n      <li>Farbcil (GT);</li>\n      <li>Farbicil (CR, DO, HN, NI, PA, SV);</li>\n      <li>Finex (PY);</li>\n      <li>Fintrix (LK);</li>\n      <li>Fungasil (IE, MT);</li>\n      <li>Funginix (DK);</li>\n      <li>Fungizid (DE);</li>\n      <li>Fungster (BE);</li>\n      <li>Funide (EC);</li>\n      <li>Futeshu (CN);</li>\n      <li>Hifen (VN);</li>\n      <li>Interbi (HK, ID);</li>\n      <li>Lamater (IE);</li>\n      <li>Lamifen (AE, JO, PH, QA, SA);</li>\n      <li>Lamisil (AE, AR, AT, AU, BE, BG, BH, BR, CH, CL, CO, CY, CZ, DK, EE, EG, ES, ET, FI, FR, GB, GR, HK, HR, ID, IL, IS, IT, JO, KR, KW, LB, LT, LU, LV, MT, MY, NL, NO, PE, PH, PK, PL, PT, PY, QA, RO, RU, SA, SE, SG, SI, SK, TH, TR, TW, UY, ZW);</li>\n      <li>Lamisil AT (ID);</li>\n      <li>Lamisil Once (AE, AU, HK, KW, LB, PH, QA, SA, TH);</li>\n      <li>Lamisilate (FR);</li>\n      <li>Lamizyl (UA);</li>\n      <li>Lan Meishu (CN);</li>\n      <li>Lisim (SG);</li>\n      <li>Medisil (QA);</li>\n      <li>Micoset (CL);</li>\n      <li>Micozone (EC);</li>\n      <li>Mujonal (CN);</li>\n      <li>Murazol (KR);</li>\n      <li>Mycelvan (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Otenol (MY);</li>\n      <li>Patir (IL);</li>\n      <li>Periafin (TW);</li>\n      <li>Ronasil Derm Gel (KR);</li>\n      <li>Sebifin (IN);</li>\n      <li>Skinabin (BD);</li>\n      <li>SolvEasy Tinea (AU, NZ);</li>\n      <li>Terafan (ET);</li>\n      <li>Terbasil (IE);</li>\n      <li>Terbex (BD);</li>\n      <li>Terbifin (BD, ZW);</li>\n      <li>Terbinorm (UA);</li>\n      <li>Terbisan (LK);</li>\n      <li>Terbisil (MT);</li>\n      <li>Terekol (AR);</li>\n      <li>Terfex (VE);</li>\n      <li>Terfina (QA);</li>\n      <li>Terfine (TW);</li>\n      <li>Terfung (TW);</li>\n      <li>Tiersil Once (KR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lamisal AT (terbinafine hydrochloride) [prescribing information]. Parsippany, NJ: Novartis Consumer Health, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lamisal (terbinafine hydrochloride) [product monograph]. Dorval, Quebec, Canada: Novartis Consumer Canada, Inc; May 2016.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9924 Version 121.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F9566190\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F9566191\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F9566196\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F9568028\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F9568027\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F9568029\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F247718\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F9566194\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms: Canada\" href=\"#F10076341\" class=\"outlineLink\">Dosage Forms: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F23348555\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F247719\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F9566186\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F247711\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F9601565\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F247709\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300113\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F247713\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F9568004\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F9568007\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F247707\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F247721\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F9572927\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961914\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9924|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=terbinafine-topical-patient-drug-information\" class=\"drug drug_patient\">Terbinafine (topical): Patient drug information</a></li><li><a href=\"topic.htm?path=terbinafine-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">Terbinafine (topical): Pediatric drug information</a></li></ul></div></div>","javascript":null}